Ofi Invest Asset Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Ofi Invest Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Ofi Invest Asset Management from 13F filings

Historical chart of Ofi Invest Asset Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Ofi Invest Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Ofi Invest Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.1M 4.9M 1.04
2024-03-31 $9.2M 4.9M 1.88
2023-09-30 $4.1M 4.4k 938.72

More positions owned by Ofi Invest Asset Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Merck & Co (MRK)
BlackRock (BLK)
Oracle Corporation (ORCL)
UnitedHealth (UNH)
Pepsi (PEP)
Goldman Sachs (GS)
salesforce (CRM)

View all positions for Ofi Invest Asset Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1